Cephazolin (DBL) is a medicine containing the active ingredient(s) cefazolin. On this page you will find out more about Cephazolin (DBL), including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.
Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.
Active ingredient in this medicine: cefazolin
Pack size information
Please select the pack size from the options directly below to view information on the medicine.
Information for medicine and pack size:
Cephazolin (DBL) 1 g powder for injection, 5 vials
Consumer Medicine Information leaflet:
This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.
What this medicine is for
Cephazolin Sodium Injection is indicated in the treatment of the following serious infections due to susceptible organisms: 1. Respiratory tract infections due to S. pneumoniae, Klebsiella species, H. influenzae, Staph. aureus (penicillin-sensitive and penicillin-resistant), and group A beta-haemolytic streptococci. Injectable benzathine penicillin is considered to be the drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. Cephazolin Sodium is effective in the eradication of streptococci from the nasopharynx; however, data establishing the efficacy of cephazolin sodium in the subsequent prevention of rheumatic fever are not available at present 2. Gentinourinary tract infections due to Esch. coli, Pr. mirabilis, Klebsiella species and some strains of Enterobacter and enterococci. 3. Skin and soft-tissue infections due to Staph. aureus (penicillin-sensitive and penicillin-resistant) and group A beta-haemolytic streptococci and other strains of streptococci. 4. Bone and joint infections due to Staph. aureus. 5. Septicaemia due to S. pneumoniae, Staph. aureus (penicillin-sensitive and penicillin- resistant), Pr. mirabilia, Esch. coli and Klebsiella species. 6. Endocarditis due to Staph. aureus (penicillin-sensitive and penicillin-resistant) and Group A beta-haemolytic streptococci. Appropriate culture and susceptibility studies should be performed to determine susceptibility of the causative organism to cephazolin sodium.
Table of characteristics
|Visual appearance||A white or slightly yellow powder|
|Dosage Form||Injection, powder for|
|Route of administration||Intravenous|
10 vials: Prescription Only Medicine, or Prescription Animal Remedy
5 vials: Prescription Only Medicine, or Prescription Animal Remedy
There is one type of pack available.
Pack type 1
|Storage temperature||Store below 25 degrees Celsius|
|Storage conditions||Protect from Light|
|Life time||3 Years|
We were unable to verify that this medicine is available on the PBS (Pharmaceutical Benefits Scheme). Please consult your pharmacist if you need further information
The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.
Is this medication banned in sport?
Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.